PL357672A1 - Nowy proces syntezy i nowa postać kryształu skondensowanych pochodnych imidazopirydyny - Google Patents

Nowy proces syntezy i nowa postać kryształu skondensowanych pochodnych imidazopirydyny

Info

Publication number
PL357672A1
PL357672A1 PL01357672A PL35767201A PL357672A1 PL 357672 A1 PL357672 A1 PL 357672A1 PL 01357672 A PL01357672 A PL 01357672A PL 35767201 A PL35767201 A PL 35767201A PL 357672 A1 PL357672 A1 PL 357672A1
Authority
PL
Poland
Prior art keywords
novel
crystal form
producing fused
imidazopyridine derivative
novel process
Prior art date
Application number
PL01357672A
Other languages
English (en)
Inventor
Fumihiko Matsubara
Takashi Ohya
Masaaki Uenaka
Original Assignee
Shionogi & Co, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co, Ltd. filed Critical Shionogi & Co, Ltd.
Publication of PL357672A1 publication Critical patent/PL357672A1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL01357672A 2000-03-30 2001-03-29 Nowy proces syntezy i nowa postać kryształu skondensowanych pochodnych imidazopirydyny PL357672A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000092565 2000-03-30
PCT/JP2001/002620 WO2001074821A1 (en) 2000-03-30 2001-03-29 Novel process for producing fused imidazopyridine derivative and novel crystal form

Publications (1)

Publication Number Publication Date
PL357672A1 true PL357672A1 (pl) 2004-07-26

Family

ID=18607880

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01357672A PL357672A1 (pl) 2000-03-30 2001-03-29 Nowy proces syntezy i nowa postać kryształu skondensowanych pochodnych imidazopirydyny

Country Status (17)

Country Link
US (1) US7049437B2 (pl)
EP (1) EP1270578A4 (pl)
JP (1) JP3481930B2 (pl)
KR (1) KR20020082898A (pl)
CN (1) CN1203073C (pl)
AU (1) AU2001244613A1 (pl)
BR (1) BR0109643A (pl)
CA (1) CA2403131A1 (pl)
CZ (1) CZ20023276A3 (pl)
HK (1) HK1054387A1 (pl)
HU (1) HUP0300580A3 (pl)
IL (1) IL151877A0 (pl)
MX (1) MXPA02009460A (pl)
NO (1) NO20024623L (pl)
PL (1) PL357672A1 (pl)
WO (1) WO2001074821A1 (pl)
ZA (1) ZA200207295B (pl)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0211169A (pt) * 2001-07-16 2004-08-10 Shionogi & Co Processo para preparação de derivados de amidina
WO2004078173A1 (ja) * 2003-02-05 2004-09-16 Shionogi & Co., Ltd. 溶出性の改善された錠剤
BRPI0413558A (pt) 2003-08-12 2006-10-17 3M Innovative Properties Co compostos contendo imidazo substituìdo por hidroxilamina
AU2004268625B2 (en) 2003-08-27 2011-03-31 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted imidazoquinolines
AU2004270201A1 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for CD5+ B cell lymphoma
AR046046A1 (es) 2003-10-03 2005-11-23 3M Innovative Properties Co Imidazoquinolinas alcoxi sustituidas. composiciones farmaceuticas.
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
CA2545825A1 (en) * 2003-11-14 2005-06-02 3M Innovative Properties Company Hydroxylamine substituted imidazo ring compounds
EP1685129A4 (en) 2003-11-14 2008-10-22 3M Innovative Properties Co OXIMSUBSTITUTED IMIDAZORING CONNECTIONS
CA2547020C (en) 2003-11-25 2014-03-25 3M Innovative Properties Company 1h-imidazo[4,5-c]pyridine-4-amine derivatives as immune response modifier
JP2007517035A (ja) 2003-12-29 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン
EP1699788A2 (en) 2003-12-30 2006-09-13 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl and imidazonaphthyridinyl sulfonamides
WO2005094531A2 (en) 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
CN1960700A (zh) * 2004-03-30 2007-05-09 荷兰联合利华有限公司 含维生素和类黄酮的亮肤组合物
US8017779B2 (en) 2004-06-15 2011-09-13 3M Innovative Properties Company Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US20070259881A1 (en) * 2004-06-18 2007-11-08 Dellaria Joseph F Jr Substituted Imidazo Ring Systems and Methods
WO2006065280A2 (en) 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006038923A2 (en) 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
JP5543068B2 (ja) 2004-12-30 2014-07-09 スリーエム イノベイティブ プロパティズ カンパニー キラル縮合[1,2]イミダゾ[4,5−c]環状化合物
EP1831221B1 (en) 2004-12-30 2012-08-08 3M Innovative Properties Company Substituted chiral fused 1,2 imidazo 4,5-c ring compounds
AU2006210392A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune response modifiers
AU2006213746A1 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo(4,5-c) ring compounds and methods
EP1869043A2 (en) 2005-04-01 2007-12-26 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
AU2006232375A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
AU2006292119A1 (en) * 2005-09-23 2007-03-29 3M Innovative Properties Company Method for 1H-imidazo[4,5-c]pyridines and analogs thereof
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
ES2966512T3 (es) * 2019-04-12 2024-04-22 Blueprint Medicines Corp Formas cristalinas de (S)-1-(4-fluorofenil)-1-(2-(4-(6-(1-metil-1H-pirazol-4-il)pirrolo[2,1-f][1,2,4]triazin-4-il)piperazinil)-pirimidin-5-il)etan-1-amina y métodos de elaboración

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378848A (en) 1992-02-12 1995-01-03 Shionogi & Co., Ltd. Condensed imidazopyridine derivatives
IL118544A (en) * 1995-06-07 2001-08-08 Smithkline Beecham Corp History of imidazole, the process for their preparation and the pharmaceutical preparations containing them

Also Published As

Publication number Publication date
EP1270578A1 (en) 2003-01-02
US7049437B2 (en) 2006-05-23
BR0109643A (pt) 2003-04-22
IL151877A0 (en) 2003-04-10
CN1419557A (zh) 2003-05-21
MXPA02009460A (es) 2003-02-12
CZ20023276A3 (cs) 2003-02-12
NO20024623L (no) 2002-11-08
HUP0300580A3 (en) 2006-06-28
HK1054387A1 (zh) 2003-11-28
CA2403131A1 (en) 2001-10-11
NO20024623D0 (no) 2002-09-26
JP3481930B2 (ja) 2003-12-22
HUP0300580A2 (hu) 2003-07-28
CN1203073C (zh) 2005-05-25
ZA200207295B (en) 2003-09-11
US20030088102A1 (en) 2003-05-08
KR20020082898A (ko) 2002-10-31
AU2001244613A1 (en) 2001-10-15
EP1270578A4 (en) 2004-11-03
WO2001074821A1 (en) 2001-10-11

Similar Documents

Publication Publication Date Title
HUP0300580A3 (en) Novel process for producing fused imidazopyridine derivative and novel crystal form
PT1293507E (pt) Processo para produção de cristais
IL154507A0 (en) Process for making n-aryl-anthranilic acids and their derivatives
SG90091A1 (en) Process for producing epsilon-caprolactam
EP1129998A4 (en) PROCESS FOR PRODUCING A QUARTZ GLASS MEMBER, AND QUARTZ GLASS MEMBER THUS PRODUCED
HUP0104566A3 (en) Process for producing n-carboxi-anhidrides
EP1193332A4 (en) PROCESS FOR PRODUCING SILICON MONOCRYSTAL
GB0125191D0 (en) Process for preparing imadacloprid
HUP0300475A3 (en) Novel stable crystal of thiazolidinedione derivative and process for producing the same
GB2370570B (en) Melting device and process for producing high-UV transmitting glass
HUP0101875A3 (en) Process for the preparation of piperidine derivatives
IL144264A0 (en) Process for producing quinolinecarbaldehyde
AU4273501A (en) Process for producing camptothecin
HUP0201903A2 (en) Benzofurane derivatives and process for producing them
EP1332116A4 (en) PROCESS FOR THE PRODUCTION OF BULK FILLER SILICA
AU2001242735A1 (en) Process for producing camptothecin
GB2363379B (en) Process for producing alpha-aminoketones
HUP0002751A3 (en) Novel grignard-reagents and process for producing thereof
HUP0103554A3 (en) Method for production of methylene-karbamide polimers
EP1310503A4 (en) PROCESS FOR THE PRODUCTION OF HYDRAZINOMONOSACCHARIDE DERIVATIVES AND THEIR USE
HU0104563D0 (en) Process for producing of food-enzymes
HUP0004469A3 (en) Process for producing trifluormethyl-aniline derivatives
IL151451A0 (en) Process for producing quinolonecarboxylic acids and intermediates thereof
AU8444201A (en) Process for producing fluoroalkanol
HUP0301141A3 (en) Method for the production of trioxime derivatives

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)